IRONWOOD PHARMACEUTICALS INC
Customers
1
1 active
Suppliers
0
None disclosed
Largest customer
100%
ABBV · FY to 2025-12-31
Named-customer revenue
$296.2M
1 customer · FY to 2025-12-31
Latest period
Dec 31, 2025
10-K filed 2026-02-26
Customers 1
Companies IRWD discloses as major customers, as a share of IRWD revenue. 1 active, 0 lapsed.
| Company | % of IRWD revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| ABBV AbbVie Inc. |
100% | $296.2M | FY 2025-12-31 | +1.0pp | Active | 10-K 2026-02-26 |
The Company does not obtain collateral for its accounts receivable.The percentages of revenue recognized from significant collaborative partners of the Company in the years ended December 31, 2025 and 2024 and the account receivable balances, net of any payables due, as of December 31, 2025 and 2024 are included in the following table: AccountsReceivable Revenue December 31, Year Ended December 31, 2025 2024 2025 2024 Collaborative Partner: AbbVie (North America and Europe) 99% 99% 100% 99% Property and EquipmentProperty and equipment, including leasehold improvements, are recorded at cost, and are depreciated when placed into service using the straight-line method based on their estimated useful lives as follows: Estimated Useful LifeAsset Description (In Years)Laboratory equipment 5Computer and office equipment 3Furniture and fixtures 7Software 3 Included in property and equipment are certain costs of software obtained for internal use. | ||||||
Alerts are coming
Get an email when IRWD's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.